Michael Secora insider trades
Open-market stock purchases and sales by Michael Secora, Chief Financial Officer at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 20, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RXRX Recursion Pharmaceuticals, Inc: 39 sales, last Nov 15, 2024